We have changed our domainWe have changed servers and operate Career|edu under a different domain. Our services will remain unchanged and we will continue to post the best career openings for the academic world at our new domain.
Go back to the Job List
Therapeutic Proteins and PeptidesPosted by: Postdoc positions by NIH
Posted date: 2020-Feb-17
A research opportunity is currently available in the Office of Tissues and Advanced Therapies (OTAT), at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
This project will develop and facilitate the application of model-informed drug development (MIDD) tools for the elucidation of pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of therapeutic products. Under the guidance of a mentor, the selected participant will leverage multiple data sources and contribute to the development of quantitative models by incorporation of mechanistic knowledge, developmental maturation and unique features of macromolecules across the pediatric age groups.
Through this research opportunity, the selected participant will have the opportunity to learn and apply computational modeling skills, including PK/PD modeling, physiologically-based pharmacokinetic modeling and quantitative system pharmacology modeling, to address public health-related issues and gain experience in developing tools geared towards the advancement of regulatory science. During the project, the participant will be actively encouraged to present the research at internal and external meetings and publish the findings in peer-reviewed journals. The training will be useful for individuals seeking careers in both academia and industry.
Anticipated Appointment Start Date: May 1, 2020
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
The qualified candidate should be currently pursuing or have received a master's or doctoral degree in Biomedical Engineering, Chemical Engineering, Life Health and Medical Sciences, Mathematics, Scientific Computing and Informatics, Statistics, or a related field. Degree must have been received within five years of the appointment start date.
This opportunity is available to US citizens and Lawful Permanent Residents (LPR) only.To Apply:
A complete application consists of:
All documents must be in English or include an official English translation.
*Applications will be reviewed on a rolling-basis.
If you have questions, send an email to ORISE.FDA.CBERorau.org. Please include the reference code for this opportunity (FDA-CBER-2020-0015) in your email.